FPC
AGN

Falcon Point Capital’s Allergan plc AGN Stock Holding History

Falcon Point Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,311
Closed -$351K – 124
2016
Q1 		$351K Buy
1,311
+198
+18% +$56.7K 0.06% 101
2015
Q4 		$348K Buy
1,113
+34
+3% +$10.1K 0.08% 98
2015
Q3 		$293K Sell
1,079
-785
-42% -$241K 0.1% 105
2015
Q2 		$566K Hold
1,864
– – 0.19% 77
2015
Q1 		$555K Sell
1,864
-120
-6% -$34.2K 0.43% 72
2014
Q4 		$511K Sell
1,984
-2,542
-56% -$635K 0.47% 76
2014
Q3 		$1.09M Sell
4,526
-1,569
-26% -$351K 0.92% 40
2014
Q2 		$1.36M Buy
6,095
+1,616
+36% +$335K 1.37% 22
2014
Q1 		$922K Buy
+4,479
New +$887K 0.89% 38

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Falcon Point Capital's AGN Position: Q2 2016 in Review

Falcon Point Capital sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 1,311 shares — an estimated $351K sold.

Falcon Point Capital first reported a position in AGN in Q1 2014 and held it in 9 quarters. The position peaked at $1.36M in Q2 2014. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • Falcon Point Capital reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
  • Falcon Point Capital sold 1,311 Allergan plc shares in Q2 2016, an estimated $351K.
  • Falcon Point Capital first reported a position in Allergan plc in Q1 2014 and held it in 9 quarters.
  • Falcon Point Capital's Allergan plc position peaked at $1.36M in Q2 2014.
  • 1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Falcon Point Capital's 13F filing for Q2 2016, filed 26 Jul 2016.